Biotech Values

[10nisman]

<< I agree 100% with you, but MNTA wasn't that "cheap" of a market cap - it had a large % of approval already bult in - the only real question was timing - next week or next year has been the question (IMO) for the last 2 years. >>

MNTA wasn't that "cheap" of a market cap prior to approval???

It had a market capitalization of approximately $440 million upon approval (excluding cash). But, I guess that's expensive for the potential of obtaining approval to serve a $2.7 billion Lovenox market as well as the potential of M356 (Copaxone - $2.5 billion market), M118, etc.. How did that short position work out for you?

10nis